Finance

Lists
532834:BOM
Camlin Fine Sciences Ltd
₹89,64
-1,39%
(-1,26) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532834...
Open
₹90,90
High
₹92,76
Low
₹89,59
Mkt. cap
17,15 mjd
Avg. vol.
45,14 k
Volume
48,24 k
P/E ratio
316,41
52-wk high
₹204,35
52-wk low
₹88,27
EPS
₹0,28
Shares outstanding
121,25 m
No. of employees
674
Open
₹90,90
High
₹92,76
Low
₹89,59
Mkt. cap
17,15 mjd
Avg. vol.
45,14 k
Volume
48,24 k
P/E ratio
316,41
52-wk high
₹204,35
52-wk low
₹88,27
EPS
₹0,28
Shares outstanding
121,25 m
No. of employees
674
News stories
From web sources and news partners
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees674
Founded1931
Headquarters-
SectorSpeciality chemicals
Last report
11 Aug. 2026
Fiscal period
Q1 2027
-₹0,99 / ₹0,12
-921,17%miss
Revenue / Est. (INR)
5,20 mjd / 5,11 mjd
+1,66%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,60 mjd
4,57 mjd
3,83 mjd
5,20 mjd
Cost of goods sold
2,47 mjd
2,48 mjd
2,24 mjd
3,06 mjd
Cost of revenue
2,47 mjd
2,48 mjd
2,24 mjd
3,06 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
602,93 m
637,64 m
886,99 m
734,29 m
Operating expense
1,99 mjd
2,04 mjd
1,52 mjd
2,16 mjd
Total operating expenses
4,45 mjd
4,52 mjd
3,76 mjd
5,21 mjd
Operating income
145,85 m
53,04 m
65,46 m
-15,12 m
Other non operating income
17,20 m
29,36 m
-94,79 m
13,40 m
EBT including unusual items
-923,00 k
-278,54 m
2,25 m
-322,59 m
EBT excluding unusual items
-923,00 k
-103,43 m
94,48 m
-211,49 m
Income tax expense
59,12 m
452,00 k
-64,02 m
-4,63 m
Effective tax rate
-6 405,31%
-0,16%
-2 849,31%
1,44%
Other operating expenses
1,19 mjd
1,23 mjd
449,93 m
1,23 mjd
Net income
-143,84 m
-362,30 m
882,02 m
-317,06 m
Net profit margin
-3,13%
-7,92%
23,05%
-6,10%
Earnings per share
-0,29
-0,94
0,76
-0,99
Interest and investment income
-
-
79,64 m
-
Interest expense
-152,05 m
-183,29 m
-76,78 m
-162,78 m
Net interest expenses
-152,05 m
-183,29 m
2,86 m
-162,78 m
Depreciation and amortization charges
188,27 m
167,28 m
184,44 m
191,56 m
EBITDA
324,59 m
203,20 m
199,10 m
118,52 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme